Aravive, Inc. (ARAV) Buy Target – $14.50 or better

Buy Target – $14.50 or better
Sell Target – TradersPro Sell Signal

Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. Its lead candidate is AVB-S6-500, a soluble Fc-fusion protein, which is in Phase 1b/2 clinical trials for the treatment of platinum- resistant recurrent ovarian cancer, as well as for the treatment of clear cell renal cell carcinoma, acute myeloid leukemia, triple negative breast cancer, and pancreatic cancer. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. is headquartered in Houston, Texas.

 
Trending Ideas

  • 2 Stocks Driving Change in Food and HR Technology

    March 29, 2025

    The food service and human resources technology sectors are undergoing significant changes driven by shifting consumer preferences and rapid technological adoption. Kellanova (K) and Paychex, Inc. (PAYX) represent companies working... Read More

  • 2 Stocks Making Big Moves in Water and Power

    March 28, 2025

    The Utilities and Water Infrastructure sectors are undergoing significant changes driven by decarbonization mandates, rising energy demand, and growing concerns over water security. Southern Company (SO) and American Water Works... Read More

  • 3 Stocks Changing the Game in Food, Utilities, and Retail

    March 28, 2025

    The Food Production, Gas Utilities, and Grocery Retail sectors are each adapting to changing consumer behavior, supply chain dynamics, and energy market pressures. Pilgrim’s Pride Corporation (PPC), ONE Gas, Inc.... Read More



Featured Stocks On The Move

© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.